Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Kulkarni

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Chemical Information and Computer Sciences|April 8, 1999
Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agentsT T Talele, V M Kulkarni
Journal of Medicinal Chemistry|February 13, 1999
Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis studyS S Kulkarni, V M Kulkarni
Journal of Computer-Aided Molecular Design|May 7, 2002
Molecular electrostatic potentials as input for the alignment of HIV-1 integrase inhibitors in 3D QSARM T Makhija, V M Kulkarni
Experientia. Supplementum|January 1, 1976
Correlation between electronic indices from molecular orbital calculations and antiradiation activity of thiazolidinesH P Tipnis, V M Kulkarni
Indian Journal of Leprosy|October 1, 1985
Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsoneV M Kulkarni, D S Mishra
Bioorganic & Medicinal Chemistry|November 1, 2000
Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) modelsV M Gokhale, V M Kulkarni
SAR and QSAR in Environmental Research|November 18, 2014
Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitorsS G Bhansali, V M Kulkarni
Drug Design and Discovery|January 5, 2002
Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexesS K Pranav Kumar, V M Kulkarni
Drug Design and Discovery|May 1, 1997
Docking analysis of a series of cytochrome P-450(14) alpha DM inhibiting azole antifungalsT T Talele, V Hariprasad, V M Kulkarni
Indian Journal of Biochemistry & Biophysics|February 1, 1992
Conformational studies on cimetidine and ranitidine by PCILO calculations and NMR spectroscopyA Saran, S Srivastava, V M Kulkarni, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Chemical Information and Computer Sciences|April 8, 1999
Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agentsT T Talele, V M Kulkarni
Journal of Medicinal Chemistry|February 13, 1999
Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis studyS S Kulkarni, V M Kulkarni
Journal of Computer-Aided Molecular Design|May 7, 2002
Molecular electrostatic potentials as input for the alignment of HIV-1 integrase inhibitors in 3D QSARM T Makhija, V M Kulkarni
Experientia. Supplementum|January 1, 1976
Correlation between electronic indices from molecular orbital calculations and antiradiation activity of thiazolidinesH P Tipnis, V M Kulkarni
Indian Journal of Leprosy|October 1, 1985
Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsoneV M Kulkarni, D S Mishra
Bioorganic & Medicinal Chemistry|November 1, 2000
Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) modelsV M Gokhale, V M Kulkarni
SAR and QSAR in Environmental Research|November 18, 2014
Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitorsS G Bhansali, V M Kulkarni
Drug Design and Discovery|January 5, 2002
Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexesS K Pranav Kumar, V M Kulkarni
Drug Design and Discovery|May 1, 1997
Docking analysis of a series of cytochrome P-450(14) alpha DM inhibiting azole antifungalsT T Talele, V Hariprasad, V M Kulkarni
Indian Journal of Biochemistry & Biophysics|February 1, 1992
Conformational studies on cimetidine and ranitidine by PCILO calculations and NMR spectroscopyA Saran, S Srivastava, V M Kulkarni, et al.
Pageof 4